Taloporfin (Laserphyrin)
Jump to navigation
Jump to search
Photosensitizer
Diseases for which it is used
History of changes in PMDA indication
- 2013-09-20: New additional indication and a new dosage for the treatment of primary malignant brain tumor (only for the case where surgical excision of tumor is performed).
- 2015-05-26: New additional indication for the treatment of recurrent esophageal cancer associated with local persistence after chemoradiotherapy or radiotherapy.
Also known as
- Brand name: Laserphyrin